Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-17-015800
Filing Date
2017-09-08
Accepted
2017-09-08 16:02:58
Documents
4
Period of Report
2017-11-01

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dffn20170907_pre14a.htm PRE 14A 209244
2 a2.jpg GRAPHIC 119027
3 a1.jpg GRAPHIC 212790
4 logo.jpg GRAPHIC 11595
  Complete submission text file 0001437749-17-015800.txt   683603
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37942 | Film No.: 171076619
SIC: 2834 Pharmaceutical Preparations